美思德(603041) - 2025 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2025 was ¥156,323,812.01, representing a year-on-year increase of 2.26%[2]. - The total profit for the period decreased by 27.55% to ¥17,266,285.02, while the net profit attributable to shareholders fell by 39.41% to ¥12,701,619.82[2][7]. - The basic earnings per share for Q3 2025 was ¥0.07, down 41.67% year-on-year, while diluted earnings per share also decreased by 41.67% to ¥0.07[2][3][7]. - The net profit excluding non-recurring gains and losses for Q3 2025 was ¥9,843,260.34, a decline of 47.82% year-on-year[2][7]. - Net profit for the first three quarters of 2025 was ¥45,167,029.81, a decrease of 39.9% from ¥74,946,288.30 in the previous year[17]. - The company reported a total profit of ¥60,961,837.79 for the first three quarters of 2025, down from ¥88,654,442.83 in 2024[17]. Cash Flow - The net cash flow from operating activities for the year-to-date period reached ¥128,985,256.95, an increase of 114.43% compared to the previous year[2][7]. - Cash flow from operating activities totaled ¥488,231,342.10, an increase from ¥415,150,542.05 in the first three quarters of 2024[19]. - Net cash flow from operating activities increased to $128,985,256.95, up from $60,153,271.52, reflecting a significant improvement[20]. - Cash inflow from financing activities was $20,000,000.00, an increase from $18,396,765.59[20]. - The total cash and cash equivalents at the end of the period decreased to $124,394,135.92 from $151,913,598.70[20]. Assets and Liabilities - The total assets at the end of the reporting period were ¥1,771,606,954.46, a decrease of 1.71% from the end of the previous year[3]. - The total current assets are ¥972,489,310.51, down from ¥1,007,724,929.91 in the previous year[12]. - The total liabilities decreased to ¥268,581,532.87 from ¥315,410,855.08 year-over-year[14]. - The total current liabilities are ¥243,001,049.34, a decrease from ¥300,856,010.58 in the previous year[13]. - The total non-current liabilities increased to ¥25,580,483.53 from ¥14,554,844.50 in the previous year[13]. Shareholder Information - The total number of common stock shareholders at the end of the reporting period is 11,992[9]. - The largest shareholder, Foshan Shunde Demai Chemical Group Co., Ltd., holds 74,865,000 shares, accounting for 40.88% of the total share capital[10]. - Total equity attributable to shareholders increased to ¥1,503,025,421.59 from ¥1,486,870,272.40 in the previous year[14]. Operational Insights - The company attributed the decline in profits to increased market competition and pressure on product sales prices[7]. - The company has strengthened its accounts receivable management, contributing to improved cash flow from operations[7]. - Research and development expenses for the first three quarters of 2025 were ¥22,925,366.52, a decrease of 16.4% compared to ¥27,424,943.21 in 2024[17]. - Non-recurring gains for the period included government subsidies amounting to ¥840,478.74[5]. Inventory and Investments - The company's accounts receivable as of September 30, 2025, is ¥96,757,975.61, compared to ¥92,682,794.52 in the previous year[12]. - The inventory as of September 30, 2025, is ¥100,291,660.68, down from ¥114,017,808.26 in the previous year[12]. - The company has a long-term equity investment of ¥6,796,709.87, unchanged from the previous year[12].